Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01066923 · ClinicalTrials.gov registry record · NA
Enhanced Firefighter Rehab Trial: The Role of Aspirin in Preventing Heat Stress Induced Platelet Activation
A NA study of Heat Stress Disorders, sponsored by Dave Hostler.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT01066923: Completed NA study of Heat Stress Disorders, sponsored by Dave Hostler.
NCT01066923 is a NA study of Heat Stress Disorders that has completed, run by Dave Hostler. The registered enrollment target is 124 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01066923, a NA study of Heat Stress Disorders, has completed, sponsored by Dave Hostler.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if aspirin taken by firefighters prevents platelets from becoming sticky when body temperature rises during work in protective clothing.
Conditions Studied
Interventions
- DRUG Daily aspirin (ASA)
- DRUG Daily placebo
- OTHER Active cooling
- DRUG Acute aspirin (ASA)
- OTHER Passive cooling
Study Locations (1)
Pennsylvania
- University of Pittsburgh, Emergency Responder Human Performance Lab - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01066923 record still lists
NCT01066923 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Heat Stress Disorders appearing as the primary indexed condition, and to 5 interventions - of which Daily aspirin (ASA) is the first listed.
NCT01066923 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01066923 about?
NCT01066923 is a clinical study titled "Enhanced Firefighter Rehab Trial: The Role of Aspirin in Preventing Heat Stress Induced Platelet Activation". The purpose of this study is to determine if aspirin taken by firefighters prevents platelets from becoming sticky when body temperature rises during work in protective clothing.
What is the current status of trial NCT01066923?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2010-02. Estimated completion is 2011-06.
What conditions does trial NCT01066923 study?
This clinical trial studies the following conditions: Heat Stress Disorders.
What interventions are being tested in trial NCT01066923?
The interventions under investigation include: Daily aspirin (ASA) (DRUG), Daily placebo (DRUG), Active cooling (OTHER), Acute aspirin (ASA) (DRUG), Passive cooling (OTHER).
Who is sponsoring clinical trial NCT01066923?
This trial is sponsored by Dave Hostler, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01066923 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heat Stress Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01066923's enrollment target sits among peer trials
124 758th of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia